Corcept Therapeutics Inc (CORT)
51.43
+0.28
(+0.55%)
USD |
NASDAQ |
Dec 20, 16:00
51.46
+0.03
(+0.06%)
After-Hours: 20:00
Corcept Therapeutics Total Liabilities (Quarterly): 145.42M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics Inc | 158.73M |
| Catalyst Pharmaceuticals Inc | 111.07M |
| Madrigal Pharmaceuticals Inc | 296.11M |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Ionis Pharmaceuticals Inc | 2.419B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 784.26M |
| Shareholders Equity (Quarterly) | 638.84M |
| Current Ratio | 3.700 |